195 related articles for article (PubMed ID: 38653236)
21. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
22. Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone.
Jungk C; Mock A; Exner J; Geisenberger C; Warta R; Capper D; Abdollahi A; Friauf S; Lahrmann B; Grabe N; Beckhove P; von Deimling A; Unterberg A; Herold-Mende C
BMC Med; 2016 Oct; 14(1):170. PubMed ID: 27782828
[TBL] [Abstract][Full Text] [Related]
23. Correlation of immune phenotype with IDH mutation in diffuse glioma.
Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M
Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337
[TBL] [Abstract][Full Text] [Related]
24. Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma.
Prabhu AH; Kant S; Kesarwani P; Ahmed K; Forsyth P; Nakano I; Chinnaiyan P
Neuro Oncol; 2019 Feb; 21(3):337-347. PubMed ID: 30476237
[TBL] [Abstract][Full Text] [Related]
25. IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma.
Kickingereder P; Sahm F; Radbruch A; Wick W; Heiland S; Deimling Av; Bendszus M; Wiestler B
Sci Rep; 2015 Nov; 5():16238. PubMed ID: 26538165
[TBL] [Abstract][Full Text] [Related]
26. Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis.
Richardson TE; Snuderl M; Serrano J; Karajannis MA; Heguy A; Oliver D; Raisanen JM; Maher EA; Pan E; Barnett S; Cai C; Habib AA; Bachoo RM; Hatanpaa KJ
J Neurooncol; 2017 May; 133(1):183-192. PubMed ID: 28421459
[TBL] [Abstract][Full Text] [Related]
27. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma.
Dao Trong P; Rösch S; Mairbäurl H; Pusch S; Unterberg A; Herold-Mende C; Warta R
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257451
[TBL] [Abstract][Full Text] [Related]
28. In vivo Metabolic Profiles as Determined by
Wenger KJ; Hattingen E; Franz K; Steinbach J; Bähr O; Pilatus U
Clin Neuroradiol; 2019 Mar; 29(1):27-36. PubMed ID: 28983683
[TBL] [Abstract][Full Text] [Related]
29. Glioma progression is shaped by genetic evolution and microenvironment interactions.
Varn FS; Johnson KC; Martinek J; Huse JT; Nasrallah MP; Wesseling P; Cooper LAD; Malta TM; Wade TE; Sabedot TS; Brat D; Gould PV; Wöehrer A; Aldape K; Ismail A; Sivajothi SK; Barthel FP; Kim H; Kocakavuk E; Ahmed N; White K; Datta I; Moon HE; Pollock S; Goldfarb C; Lee GH; Garofano L; Anderson KJ; Nehar-Belaid D; Barnholtz-Sloan JS; Bakas S; Byrne AT; D'Angelo F; Gan HK; Khasraw M; Migliozzi S; Ormond DR; Paek SH; Van Meir EG; Walenkamp AME; Watts C; Weiss T; Weller M; Palucka K; Stead LF; Poisson LM; Noushmehr H; Iavarone A; Verhaak RGW;
Cell; 2022 Jun; 185(12):2184-2199.e16. PubMed ID: 35649412
[TBL] [Abstract][Full Text] [Related]
30. [Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].
Pan Y; Qi XL; Wang LM; Dong RF; Zhang M; Zheng DF; Chang Q; Zhong YF
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):292-8. PubMed ID: 24004584
[TBL] [Abstract][Full Text] [Related]
31. Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients.
Li T; Yang Z; Li H; Zhu J; Wang Y; Tang Q; Shi Z
Lab Invest; 2022 Feb; 102(2):143-153. PubMed ID: 34697421
[TBL] [Abstract][Full Text] [Related]
32. IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic glioma.
Gorovets D; Kannan K; Shen R; Kastenhuber ER; Islamdoust N; Campos C; Pentsova E; Heguy A; Jhanwar SC; Mellinghoff IK; Chan TA; Huse JT
Clin Cancer Res; 2012 May; 18(9):2490-501. PubMed ID: 22415316
[TBL] [Abstract][Full Text] [Related]
33. Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.
Gerardo Valadez J; Grover VK; Carter MD; Calcutt MW; Abiria SA; Lundberg CJ; Williams TV; Cooper MK
Cancer Lett; 2013 Jan; 328(2):297-306. PubMed ID: 23063752
[TBL] [Abstract][Full Text] [Related]
34. Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity.
Raviram R; Raman A; Preissl S; Ning J; Wu S; Koga T; Zhang K; Brennan CW; Zhu C; Luebeck J; Van Deynze K; Han JY; Hou X; Ye Z; Mischel AK; Li YE; Fang R; Baback T; Mugford J; Han CZ; Glass CK; Barr CL; Mischel PS; Bafna V; Escoubet L; Ren B; Chen CC
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2210991120. PubMed ID: 37155843
[TBL] [Abstract][Full Text] [Related]
35. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
[TBL] [Abstract][Full Text] [Related]
36. Proteogenomics of glioblastoma associates molecular patterns with survival.
Yanovich-Arad G; Ofek P; Yeini E; Mardamshina M; Danilevsky A; Shomron N; Grossman R; Satchi-Fainaro R; Geiger T
Cell Rep; 2021 Mar; 34(9):108787. PubMed ID: 33657365
[TBL] [Abstract][Full Text] [Related]
37. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
[TBL] [Abstract][Full Text] [Related]
38. Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.
Easwaran TP; Lancki N; Henriquez M; Vortmeyer AO; Barbaro NM; Scholtens DM; Ahmed AU; Dey M
Neuromolecular Med; 2021 Jun; 23(2):315-326. PubMed ID: 33206320
[TBL] [Abstract][Full Text] [Related]
39. Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.
Park YW; Kim S; Han K; Ahn SS; Moon JH; Kim EH; Kim J; Kang SG; Kim SH; Lee SK; Chang JH
Eur Radiol; 2024 Feb; 34(2):1376-1387. PubMed ID: 37608093
[TBL] [Abstract][Full Text] [Related]
40. Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.
Wu L; Zhao Z; Shin YJ; Yin Y; Raju A; Vaiyapuri TS; Idzham K; Son M; Lee Y; Sa JK; Chua JYH; Unal B; Zhai Y; Fan W; Huang L; Hu H; Gunaratne J; Nam DH; Jiang T; Tergaonkar V
Nat Cell Biol; 2024 Jun; 26(6):1003-1018. PubMed ID: 38858501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]